RafaelFonsecaMD
Hematology • Scottsdale, AZGetz Family Professor of Cancer, Professor of Medicine, Mayo Medical School Distinguished Mayo Investigator
Dr. Fonseca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1994 - 1998
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1991 - 1994
Universidad Anahuac School of MedicineClass of 1991
Certifications & Licensure
AZ State Medical License 2004 - 2026
MN State Medical License 1994 - 2004- American Board of Internal Medicine Hematology
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Clinical Trials
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma Start of enrollment: 2004 Nov 03
- Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone Start of enrollment: 2007 Sep 01
- Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2005 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsProteomic analysis of waldenstrom macroglobulinemia.Evdoxia Hatjiharissi, Hai Ngo, Alexey A. Leontovich, Xavier Leleu, Michael Timm
Cancer Research. 2007-04-15 - 199 citationsPilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.Charles L. Loprinzi, Thomas M. Pisansky, Rafael Fonseca, Jeff A. Sloan, Katherine M. Zahasky
Journal of Clinical Oncology. 1998-07-01 - 446 citationsIMWG consensus on risk stratification in multiple myelomaWee Joo Chng, Angela Dispenzieri, C. S. Chim, R Fonseca, H. Goldschmidt
Leukemia. 2014-02-01
Journal Articles
- Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
Abstracts/Posters
- Myeloma Cells Addicted to Glutamine for Biomass Production Are Sensitive to LenalidomideRafael Fonseca, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Current Obstacles in Myeloma Management: Debating the Evidence61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrom Macroglobulinemia, and Amyloidosis60th American Society of Hematology Annual Meeting - 11/30/2018
- Join now to see all
Press Mentions
7 Advances in CAR-T Cell Therapy at Mayo ClinicSeptember 19th, 2024- New Innovations Improve Cancer CareFebruary 3rd, 2023
- ISHOF CEO Brent Rutemiller Continues to Battle Leukemia; Will Work with Mayo ClinicAugust 17th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
